# Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage

> **NCT04558814** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DIAGNOSTIC_TEST:** Serum galectin-9 level

## Key facts

- **NCT ID:** NCT04558814
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558814, "Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04558814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*